Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

What variables predict cognitive remediation associated improvement in individuals with psychosis?

Fiszdon JM, Kurtz MM, Parente L, Choi J.

Schizophr Res Cogn. 2019 May 1;19:100148. doi: 10.1016/j.scog.2019.100148. eCollection 2020 Mar.

2.

The synergistic benefits of physical and cognitive exercise in schizophrenia: Promoting motivation to enhance community effectiveness.

Choi J, Taylor B, Fiszdon JM, Kurtz MM, Tek C, Dewberry MJ, Haber LC, Shagan D, Assaf M, Pearlson GD.

Schizophr Res Cogn. 2019 Apr 25;19:100147. doi: 10.1016/j.scog.2019.100147. eCollection 2020 Mar.

3.

Pharmacological AMPK activation induces transcriptional responses congruent to exercise in skeletal and cardiac muscle, adipose tissues and liver.

Muise ES, Guan HP, Liu J, Nawrocki AR, Yang X, Wang C, Rodríguez CG, Zhou D, Gorski JN, Kurtz MM, Feng D, Leavitt KJ, Wei L, Wilkening RR, Apgar JM, Xu S, Lu K, Feng W, Li Y, He H, Previs SF, Shen X, van Heek M, Souza SC, Rosenbach MJ, Biftu T, Erion MD, Kelley DE, Kemp DM, Myers RW, Sebhat IK.

PLoS One. 2019 Feb 27;14(2):e0211568. doi: 10.1371/journal.pone.0211568. eCollection 2019.

4.

Objective psychosocial function vs. subjective quality-of-life in schizophrenia within 5-years after diagnosis: A study from southern India.

Kurtz MM, Gopal S, John S, Thara R.

Psychiatry Res. 2019 Feb;272:419-424. doi: 10.1016/j.psychres.2018.12.149. Epub 2018 Dec 29.

PMID:
30611958
5.

The effects of cognitive-focused interventions on cognition and psychological well-being in persons with multiple sclerosis: A meta-analysis.

Gromisch ES, Fiszdon JM, Kurtz MM.

Neuropsychol Rehabil. 2018 Jul 5:1-20. doi: 10.1080/09602011.2018.1491408. [Epub ahead of print]

PMID:
29973121
6.

Cognition, social cognition and functional disability in early-stage schizophrenia: A study from southern India.

Kurtz MM, Gopal S, John S, Thara R.

Psychiatry Res. 2018 Jul;265:231-237. doi: 10.1016/j.psychres.2018.03.091. Epub 2018 Apr 24.

PMID:
29753255
7.

Discovery of MK-8722: A Systemic, Direct Pan-Activator of AMP-Activated Protein Kinase.

Feng D, Biftu T, Romero FA, Kekec A, Dropinski J, Kassick A, Xu S, Kurtz MM, Gollapudi A, Shao Q, Yang X, Lu K, Zhou G, Kemp D, Myers RW, Guan HP, Trujillo ME, Li C, Weber A, Sebhat IK.

ACS Med Chem Lett. 2017 Dec 1;9(1):39-44. doi: 10.1021/acsmedchemlett.7b00417. eCollection 2018 Jan 11.

8.

Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy.

Myers RW, Guan HP, Ehrhart J, Petrov A, Prahalada S, Tozzo E, Yang X, Kurtz MM, Trujillo M, Gonzalez Trotter D, Feng D, Xu S, Eiermann G, Holahan MA, Rubins D, Conarello S, Niu X, Souza SC, Miller C, Liu J, Lu K, Feng W, Li Y, Painter RE, Milligan JA, He H, Liu F, Ogawa A, Wisniewski D, Rohm RJ, Wang L, Bunzel M, Qian Y, Zhu W, Wang H, Bennet B, LaFranco Scheuch L, Fernandez GE, Li C, Klimas M, Zhou G, van Heek M, Biftu T, Weber A, Kelley DE, Thornberry N, Erion MD, Kemp DM, Sebhat IK.

Science. 2017 Aug 4;357(6350):507-511. doi: 10.1126/science.aah5582. Epub 2017 Jul 13.

PMID:
28705990
9.

Verbal Learning and Memory Enhancement Strategies in Schizophrenia: A Randomized, Controlled Investigation.

Kurtz MM, Trask CL, Rosengard R, Hyman S, Kremen L, Mehta S, Olfson R, Rispaud S, Zaidman S, Choi J.

J Int Neuropsychol Soc. 2017 Apr;23(4):352-357. doi: 10.1017/S1355617717000042. Epub 2017 Mar 13.

PMID:
28287057
10.

Cognitive remediation for adults with schizophrenia: Does age matter?

Corbera S, Wexler BE, Poltorak A, Thime WR, Kurtz MM.

Psychiatry Res. 2017 Jan;247:21-27. doi: 10.1016/j.psychres.2016.10.084. Epub 2016 Nov 11.

11.

Can brain games help smokers quit?: Results of a randomized clinical trial.

Loughead J, Falcone M, Wileyto EP, Albelda B, Audrain-McGovern J, Cao W, Kurtz MM, Gur RC, Lerman C.

Drug Alcohol Depend. 2016 Nov 1;168:112-118. doi: 10.1016/j.drugalcdep.2016.08.621. Epub 2016 Aug 27.

PMID:
27635998
12.

Neuroplastic Changes Following Social Cognition Training in Schizophrenia: A Systematic Review.

Campos C, Santos S, Gagen E, Machado S, Rocha S, Kurtz MM, Rocha NB.

Neuropsychol Rev. 2016 Sep;26(3):310-328. Epub 2016 Aug 19. Review.

PMID:
27541742
13.

The relationship between change in cognition and change in functional ability in schizophrenia during cognitive and psychosocial rehabilitation.

Rispaud SG, Rose J, Kurtz MM.

Psychiatry Res. 2016 Oct 30;244:145-50. doi: 10.1016/j.psychres.2016.07.033. Epub 2016 Jul 20.

PMID:
27479105
14.

Comprehensive treatments for social cognitive deficits in schizophrenia: A critical review and effect-size analysis of controlled studies.

Kurtz MM, Gagen E, Rocha NB, Machado S, Penn DL.

Clin Psychol Rev. 2016 Feb;43:80-9. doi: 10.1016/j.cpr.2015.09.003. Epub 2015 Sep 25. Review.

PMID:
26437567
15.

Motivational Interviewing to Increase Cognitive Rehabilitation Adherence in Schizophrenia.

Fiszdon JM, Kurtz MM, Choi J, Bell MD, Martino S.

Schizophr Bull. 2016 Mar;42(2):327-34. doi: 10.1093/schbul/sbv143. Epub 2015 Sep 29.

16.

Division III Collision Sports Are Not Associated with Neurobehavioral Quality of Life.

Meehan WP 3rd, Taylor AM, Berkner P, Sandstrom NJ, Peluso MW, Kurtz MM, Pascual-Leone A, Mannix R.

J Neurotrauma. 2016 Jan 15;33(2):254-9. doi: 10.1089/neu.2015.3930. Epub 2015 Jul 20.

17.

Social skills training and computer-assisted cognitive remediation in schizophrenia.

Kurtz MM, Mueser KT, Thime WR, Corbera S, Wexler BE.

Schizophr Res. 2015 Mar;162(1-3):35-41. doi: 10.1016/j.schres.2015.01.020. Epub 2015 Jan 29.

18.

Skill building: assessing the evidence.

Lyman DR, Kurtz MM, Farkas M, George P, Dougherty RH, Daniels AS, Ghose SS, Delphin-Rittmon ME.

Psychiatr Serv. 2014 Jun 1;65(6):727-38. doi: 10.1176/appi.ps.201300251. Review.

PMID:
24749145
19.

Adjunctive pharmacotherapy for cognitive deficits in schizophrenia: meta-analytical investigation of efficacy.

Choi KH, Wykes T, Kurtz MM.

Br J Psychiatry. 2013 Sep;203(3):172-8. doi: 10.1192/bjp.bp.111.107359. Review. Erratum in: Br J Psychiatry. 2013 Nov;203(5):392.

20.

Current trends in the empirical study of cognitive remediation for schizophrenia.

Saperstein AM, Kurtz MM.

Can J Psychiatry. 2013 Jun;58(6):311-8. Review.

PMID:
23768258
21.

Self-efficacy and functional status in schizophrenia: relationship to insight, cognition and negative symptoms.

Kurtz MM, Olfson RH, Rose J.

Schizophr Res. 2013 Apr;145(1-3):69-74. doi: 10.1016/j.schres.2012.12.030. Epub 2013 Feb 1.

22.

In individuals with schizophrenia, duration and severity of mental illness, health status, mutuality, employment and household income influence quality of life.

Kurtz MM.

Evid Based Nurs. 2013 Jul;16(3):79-80. doi: 10.1136/eb-2012-101050. Epub 2012 Dec 12. No abstract available.

PMID:
23236219
23.

Cognitive remediation for schizophrenia: current status, biological correlates and predictors of response.

Kurtz MM.

Expert Rev Neurother. 2012 Jul;12(7):813-21. doi: 10.1586/ern.12.71. Review.

PMID:
22853789
24.

Evaluating lexical characteristics of verbal fluency output in schizophrenia.

Juhasz BJ, Chambers D, Shesler LW, Haber A, Kurtz MM.

Psychiatry Res. 2012 Dec 30;200(2-3):177-83. doi: 10.1016/j.psychres.2012.06.035. Epub 2012 Jul 17.

25.

Cognitive and social cognitive predictors of change in objective versus subjective quality-of-life in rehabilitation for schizophrenia.

Kurtz MM, Bronfeld M, Rose J.

Psychiatry Res. 2012 Dec 30;200(2-3):102-7. doi: 10.1016/j.psychres.2012.06.025. Epub 2012 Jul 4.

26.

Crystallized verbal skills in schizophrenia: relationship to neurocognition, symptoms, and functional status.

Kurtz MM, Donato J, Rose J.

Neuropsychology. 2011 Nov;25(6):784-791. doi: 10.1037/a0025534.

PMID:
21928906
27.

High-throughput simultaneous analysis of RNA, protein, and lipid biomarkers in heterogeneous tissue samples.

Reiser V, Smith RC, Xue J, Kurtz MM, Liu R, Legrand C, He X, Yu X, Wong P, Hinchcliffe JS, Tanen MR, Lazar G, Zieba R, Ichetovkin M, Chen Z, O'Neill EA, Tanaka WK, Marton MJ, Liao J, Morris M, Hailman E, Tokiwa GY, Plump AS.

Clin Chem. 2011 Nov;57(11):1545-55. doi: 10.1373/clinchem.2010.157743. Epub 2011 Sep 13.

PMID:
21914789
28.

Neuropsychological functioning in hoarding disorder.

Tolin DF, Villavicencio A, Umbach A, Kurtz MM.

Psychiatry Res. 2011 Oct 30;189(3):413-8. doi: 10.1016/j.psychres.2011.06.022. Epub 2011 Jul 20.

29.

Social cognitive training for schizophrenia: a meta-analytic investigation of controlled research.

Kurtz MM, Richardson CL.

Schizophr Bull. 2012 Sep;38(5):1092-104. doi: 10.1093/schbul/sbr036. Epub 2011 Apr 27.

30.

Neurocognition as a predictor of response to evidence-based psychosocial interventions in schizophrenia: what is the state of the evidence?

Kurtz MM.

Clin Psychol Rev. 2011 Jun;31(4):663-72. doi: 10.1016/j.cpr.2011.02.008. Epub 2011 Feb 26. Review.

31.

Neurocognition, insight into illness and subjective quality-of-life in schizophrenia: what is their relationship?

Kurtz MM, Tolman A.

Schizophr Res. 2011 Apr;127(1-3):157-62. doi: 10.1016/j.schres.2010.12.004. Epub 2011 Jan 6.

32.

Predictors of participation in community outpatient psychosocial rehabilitation in schizophrenia.

Kurtz MM, Rose J, Wexler BE.

Community Ment Health J. 2011 Dec;47(6):622-7. doi: 10.1007/s10597-010-9343-z. Epub 2010 Jul 30.

33.

Neurocognitive predictors of objective and subjective quality of life in individuals with schizophrenia: a meta-analytic investigation.

Tolman AW, Kurtz MM.

Schizophr Bull. 2012 Mar;38(2):304-15. doi: 10.1093/schbul/sbq077. Epub 2010 Jul 11.

34.

Tetrahydroindolizinone NK1 antagonists.

Bao J, Lu H, Morriello GJ, Carlson EJ, Wheeldon A, Chicchi GG, Kurtz MM, Tsao KL, Zheng S, Tong X, Mills SG, DeVita RJ.

Bioorg Med Chem Lett. 2010 Apr 1;20(7):2354-8. doi: 10.1016/j.bmcl.2010.01.120. Epub 2010 Feb 1.

PMID:
20188553
35.

Elementary neurocognitive function, learning potential and everyday life skills in schizophrenia: what is their relationship?

Kurtz MM, Jeffrey SB, Rose J.

Schizophr Res. 2010 Feb;116(2-3):280-8. doi: 10.1016/j.schres.2009.08.011. Epub 2009 Sep 10.

36.

A meta-analytic investigation of neurocognitive deficits in bipolar illness: profile and effects of clinical state.

Kurtz MM, Gerraty RT.

Neuropsychology. 2009 Sep;23(5):551-62. doi: 10.1037/a0016277.

37.

Potent, brain-penetrant, hydroisoindoline-based human neurokinin-1 receptor antagonists.

Jiang J, Bunda JL, Doss GA, Chicchi GG, Kurtz MM, Tsao KL, Tong X, Zheng S, Upthagrove A, Samuel K, Tschirret-Guth R, Kumar S, Wheeldon A, Carlson EJ, Hargreaves R, Burns D, Hamill T, Ryan C, Krause SM, Eng W, DeVita RJ, Mills SG.

J Med Chem. 2009 May 14;52(9):3039-46. doi: 10.1021/jm8016514.

PMID:
19354254
38.

Elementary neurocognitive function, facial affect recognition and social-skills in schizophrenia.

Meyer MB, Kurtz MM.

Schizophr Res. 2009 May;110(1-3):173-9. doi: 10.1016/j.schres.2009.03.015. Epub 2009 Mar 27.

39.

Predictors of change in life skills in schizophrenia after cognitive remediation.

Kurtz MM, Seltzer JC, Fujimoto M, Shagan DS, Wexler BE.

Schizophr Res. 2009 Feb;107(2-3):267-74. doi: 10.1016/j.schres.2008.10.014. Epub 2008 Nov 8.

40.

A comparison of remediation techniques on the Wisconsin Card Sorting Test in schizophrenia.

Choi J, Kurtz MM.

Schizophr Res. 2009 Jan;107(1):76-82. doi: 10.1016/j.schres.2008.09.017. Epub 2008 Oct 19.

41.

A meta-analysis of controlled research on social skills training for schizophrenia.

Kurtz MM, Mueser KT.

J Consult Clin Psychol. 2008 Jun;76(3):491-504. doi: 10.1037/0022-006X.76.3.491.

PMID:
18540742
42.

Symptoms versus neurocognition as predictors of change in life skills in schizophrenia after outpatient rehabilitation.

Kurtz MM, Wexler BE, Fujimoto M, Shagan DS, Seltzer JC.

Schizophr Res. 2008 Jul;102(1-3):303-11. doi: 10.1016/j.schres.2008.03.023. Epub 2008 May 20.

43.

Fused bicyclic pyrrolizinones as new scaffolds for human NK1 antagonists.

Morriello GJ, Devita RJ, Mills SG, Young JR, Lin P, Doss G, Chicchi GG, Demartino J, Kurtz MM, Tsao KL, Carlson E, Townson K, Wheeldon A, Boyce S, Collinson N, Rupniak N, Moore S.

Bioorg Med Chem. 2008 Mar 1;16(5):2156-70. doi: 10.1016/j.bmc.2007.11.081. Epub 2007 Dec 5.

PMID:
18248994
44.

Pyrrolidine-carboxamides and oxadiazoles as potent hNK1 antagonists.

Young JR, Eid R, Turner C, DeVita RJ, Kurtz MM, Tsao KL, Chicchi GG, Wheeldon A, Carlson E, Mills SG.

Bioorg Med Chem Lett. 2007 Oct 1;17(19):5310-5. Epub 2007 Aug 16.

PMID:
17723300
45.

The discovery of potent, selective, and orally bioavailable hNK1 antagonists derived from pyrrolidine.

Lin P, Chang L, Devita RJ, Young JR, Eid R, Tong X, Zheng S, Ball RG, Tsou NN, Chicchi GG, Kurtz MM, Tsao KL, Wheeldon A, Carlson EJ, Eng W, Burns HD, Hargreaves RJ, Mills SG.

Bioorg Med Chem Lett. 2007 Sep 15;17(18):5191-8. Epub 2007 Jul 4.

PMID:
17637506
46.

Computer-assisted cognitive remediation in schizophrenia: what is the active ingredient?

Kurtz MM, Seltzer JC, Shagan DS, Thime WR, Wexler BE.

Schizophr Res. 2007 Jan;89(1-3):251-60. Epub 2006 Oct 27.

47.

A virtual reality apartment as a measure of medication management skills in patients with schizophrenia: a pilot study.

Kurtz MM, Baker E, Pearlson GD, Astur RS.

Schizophr Bull. 2007 Sep;33(5):1162-70. Epub 2006 Sep 6.

48.

Virtual reality assessment of medication compliance in patients with schizophrenia.

Baker EK, Kurtz MM, Astur RS.

Cyberpsychol Behav. 2006 Apr;9(2):224-9.

PMID:
16640484
49.

NK1 antagonists based on seven membered lactam scaffolds.

Elliott JM, Carlson EJ, Chicchi GG, Dirat O, Dominguez M, Gerhard U, Jelley R, Jones AB, Kurtz MM, Tsao Kl, Wheeldon A.

Bioorg Med Chem Lett. 2006 Jun 1;16(11):2929-32. Epub 2006 Mar 29.

PMID:
16574413
50.

Supplemental Content

Loading ...
Support Center